glp 1 drugs and vision loss GLP-1 are associated with a 35% higher risk of NAION, an eye condition that can cause sudden loss. About 6 to 10 extra cases per 10,000 users over 3 years Ozempic and vision loss: GLP-1
Description
O'Reilly MW, House PJ, Tomlinson JW

For instance, Wegovy is a GLP-1 RA specifically approved for weight loss while also being researched for other medical uses such as metabolic conditions

Khizer Sohail Sheikh: Data curation, Writing original draft, Writing review & editing, Visualization
Although overall findings support a cardioprotective effect of GLP-1 RAs, the ITCA 650 trial showed directionally higher hazard ratios for several outcomes

Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase

PMID:17306374
